Pain Management: Avoid These Top Interlaminar Injection Pitfalls

Why This Topic Matters

Interlaminar epidural injection claims are frequently denied when region, level, imaging, or diagnosis details are misunderstood. This guidance helps readers recognize the main coding and documentation issues that can affect claim acceptance and payer review.

Article Sections

1. Skip the Bilateral Modifier

   This section discusses reporting considerations for interlaminar epidural injections performed in the same spinal region and highlights common modifier-related pitfalls. It also references payer and fee schedule treatment of bilateral reporting.

2. Watch Levels, Not Injections

   This section explains the distinction between spinal region and level in relation to interlaminar epidural injection claims. It also addresses common language mismatches between provider documentation and payer preauthorization.

3. Remember Separate Fluoro Is OK

   This section covers separate reporting considerations for fluoroscopic guidance when used during spine injection procedures. It also notes the role of coding edits in relation to the procedure pair discussed.

4. Assign the Correct Diagnosis

   This section reviews diagnosis selection for interlaminar epidural injection claims and discusses payer medical necessity policies. It emphasizes documentation alignment with the physician's recorded condition.